United Laboratories International : LOAN FACILITY WITH CHINA DEVELOPMENT BANK - ANNOUNCEMENT PURSUANT TO RULE 13.18 OF THE LISTING RULES

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

The United Laboratories International Holdings Limited

聯邦制藥國際控股有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 3933)

LOAN FACILITY WITH CHINA DEVELOPMENT BANK -

ANNOUNCEMENT PURSUANT TO RULE 13.18 OF THE LISTING RULES

United Laboratories (Inner Mongolia), as borrower, entered into a facility agreement with China Development Bank Hong Kong Branch for HK$300,000,000term loan facility. The loans under the facility shall be repaid by installments with the final repayment date falling 60 months from the first utilisation date.

The Agreement imposes, among other matters, a minimum shareholding percentage in the Company by its controlling shareholders.

This announcement is made pursuant to Rule 13.18 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules").

The board of directors (the "Board") of The United Laboratories International Holdings Limited (the "Company") announces that the Company's indirect wholly-owned subsidiary The United Laboratories (Inner Mongolia) Co., Ltd. ("United Laboratories (Inner Mongolia)"), as borrower, entered into a facility agreement (the "Agreement") dated 23 September 2019 with China Development Bank Hong Kong Branch for HK$300,000,000 term loan facility. The loans under the facility shall be repaid by installments with the final repayment date falling 60 months from the first utilisation date.

The Agreement imposes, among other matters, Mr. Tsoi Hoi Shan, Ms. Choy Siu Chit, Ms. Ning Kwai Chun and their family trusts collectively to own more than 51% of the entire issued capital of the Company.

The Company will continue to comply with the disclosure obligations under Rule 13.21 of the Listing Rules for so long as circumstance giving rise to the above obligation continue to exist.

On behalf of the Board

The United Laboratories International Holdings Limited

Tsoi Hoi Shan

Chairman

Hong Kong, 23 October 2019

- 1 -

As at the date of this announcement, the Board comprises Mr. Tsoi Hoi Shan, Mr. Leung Wing Hon, Ms. Choy Siu Chit, Mr. Fang Yu Ping, Ms. Zou Xian Hong and Ms. Zhu Su Yan as executive directors; and Mr. Chong Peng Oon, Prof. Song Ming and Ms. Fu Xiao Nan as independent non-executive directors.

- 2 -